 Home > Chemicals Industry > China Chemical > Under the upgrading of the pharmaceutical industry, the upstream pharmaceutical equipment industry has changed and remained unchanged

Under the upgrading of the pharmaceutical industry, the upstream pharmaceutical equipment industry has changed and remained unchanged

 Last Update: 2022-06-07
 Source: Internet
 Author: User

Tags

small italian

basic lab equipment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[ Market Analysis of Chemical Machinery Equipment Network ] Changing and unchanging is the survival way for pharmaceutical equipment companies to take advantage of the trend, and it is also the road to stable and far-reaching development.

Chemical machinery and equipment network market analysis chemical machinery and equipment

2020 is an unusual year.
For the pharmaceutical equipment industry, opportunities and challenges coexist.
Under the normalization of centralized procurement and the negotiation of new medical insurance, the pharmaceutical industry is forced to upgrade, which brings opportunities to the upstream pharmaceutical equipment industry, but also puts forward higher requirements for pharmaceutical equipment.
This article mainly analyzes the changes and changes in the upstream pharmaceutical equipment industry under the upgrading of the pharmaceutical industry.

Pharmaceutical equipment companies have changed to a development model, and they need to move forward in the direction of advancing with the times and constantly exploring.

For example, internally, in the context of rising corporate costs and rising raw material prices, more and more pharmaceutical machinery companies have adopted sophisticated management to reasonably control costs.

　　Judging from the transcripts of pharmaceutical companies that have disclosed the 2020 annual report, companies that continue to fine-tune management have greatly reduced the proportion of costs and expenses in revenue.
For example, Tofflon, which achieved a net profit of 172 million yuan in the first half of the year and a year-on-year increase of 350.
16%, stated in the report that the company continued to implement the concept of precise management and implemented digital reforms, and the proportion of material costs and expenses in operating income decreased compared with the same period last year.
.

　　For another example, in terms of the needs of the downstream pharmaceutical industry, pharmaceutical companies have gone from pursuing low-end, low-level, to high-precision technology and chemical equipment.
In this context, the industry also generally recognizes the lack of domestic equipment and the shortage of high-tech pharmaceutical machine manufacturers.
It is focusing on strengthening technological innovation, continuously improving the automation, intelligence, and information level of pharmaceutical production, and accelerating the realization of domestic production in the field.
Substitute.

　　Recently, pharmaceutical equipment has also ushered in a big favorable policy to support the development of the pharmaceutical equipment industry in the direction of chemistry, which will add impetus to the high-quality development of domestic pharmaceutical equipment.

　　What remains unchanged is that market competition has intensified and industry concentration still has room for growth.

　　Judging from the overall development of the pharmaceutical machinery industry, the industry concentration has increased in recent years and market competition has been fierce.
Small and medium-sized pharmaceutical machinery companies have a small layout and investment in new products and new technologies, while large pharmaceutical machinery companies have relatively strong advantages in market layout and diversified development.

　　For example, Chutian mentioned in the 2020 semi-annual report that the company's investment in R&D, core manufacturing capabilities and quality assurance capabilities continued to increase in the first half of this year.
Chutian's core competitiveness and brand influence have been further improved, and the market situation is welcome.
Here comes a new breakthrough.

　　In the first half of this year, Tofflon actively guaranteed and promoted the preset domestic project delivery plan, always paid attention to the progress of the project, maintained effective communication with customers through online methods, quickly responded to customer needs, and achieved both revenue and net profit growth.

　　In addition, the issue of product homogeneity has been plagued by the development of the industry.
In response to the problem of product homogeneity, pharmaceutical machinery companies with technical and financial capabilities are strengthening R&D and innovation, and at the same time actively expanding the market, speeding up the development process while meeting the needs of the domestic market.
The 2018 report shows that the average growth rate of the annual export delivery value of China's pharmaceutical equipment industry has reached 23.
075%.

Pharmaceutical equipment

　　Conclusion

　　With the increasingly fierce competition in the pharmaceutical equipment industry, these "changes" will become the core competitiveness of pharmaceutical machinery companies, and "unchanged" will be the driving force for companies to upgrade.
It will help accelerate the transformation and upgrading of the industry, and will also help the pharmaceutical industry go further on the road of high-quality development.

　　Original title: Under the upgrading of the pharmaceutical industry, the upstream pharmaceutical equipment industry changes and remains unchanged

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.